NDC Labeler Amgen Inc
Amgen Inc labeler's code is 55513. The labeler has 88 products that have an assigned National Drug Code.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Product Type | Status |
---|---|---|---|---|---|---|
55513-002 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-003 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-004 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-005 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-006 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-021 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-023 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-025 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-027 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-028 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-032 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-057 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-073 | Sensipar | Cinacalcet Hydrochloride | Tablet, Coated | Oral | Human Prescription Drug | ACTIVE |
55513-074 | Sensipar | Cinacalcet Hydrochloride | Tablet, Coated | Oral | Human Prescription Drug | ACTIVE |
55513-075 | Sensipar | Cinacalcet Hydrochloride | Tablet, Coated | Oral | Human Prescription Drug | ACTIVE |
55513-078 | Imlygic | Talimogene Laherparepvec | Injection, Suspension | Intralesional | Human Prescription Drug | ACTIVE |
55513-079 | Imlygic | Talimogene Laherparepvec | Injection, Suspension | Intralesional | Human Prescription Drug | ACTIVE |
55513-098 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-100 | Tezspire | Tezepelumab-ekko | Injection, Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-110 | Aranesp | Darbepoetin Alfa | Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-111 | Aranesp | Darbepoetin Alfa | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-112 | Tezspire | Tezepelumab-ekko | Injection, Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-123 | Tezspire | Tezepelumab-ekko | Injection, Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-126 | Epogen | Epoetin Alfa | Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-132 | Kanjinti | Trastuzumab-anns | Injection, Powder, Lyophilized, For Solution | Intravenous | Human Prescription Drug | ACTIVE |
55513-137 | Otezla | Apremilast | Tablet, Film Coated | Oral | Human Prescription Drug | ACTIVE |
55513-141 | Kanjinti | Trastuzumab-anns | Injection, Powder, Lyophilized, For Solution | Intravenous | Human Prescription Drug | ACTIVE |
55513-144 | Epogen | Epoetin Alfa | Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-148 | Epogen | Epoetin Alfa | Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-160 | Blincyto | Blinatumomab | Kit | Human Prescription Drug | ACTIVE | |
55513-164 | Kanjinti | Trastuzumab-anns | Kit | Human Prescription Drug | ACTIVE | |
55513-190 | Neulasta | Pegfilgrastim | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-192 | Neulasta | Pegfilgrastim | Kit | Human Prescription Drug | ACTIVE | |
55513-206 | Mvasi | Bevacizumab-awwb | Injection, Solution | Intravenous | Human Prescription Drug | ACTIVE |
55513-207 | Mvasi | Bevacizumab-awwb | Injection, Solution | Intravenous | Human Prescription Drug | ACTIVE |
55513-209 | Neupogen | Filgrastim | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-221 | Nplate | Romiplostim | Injection, Powder, Lyophilized, For Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-222 | Nplate | Romiplostim | Injection, Powder, Lyophilized, For Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-223 | Nplate | Romiplostim | Injection, Powder, Lyophilized, For Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-224 | Riabni | Rituximab-arrx | Injection, Solution | Intravenous | Human Prescription Drug | ACTIVE |
55513-267 | Epogen | Epoetin Alfa | Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-283 | Epogen | Epoetin Alfa | Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-326 | Riabni | Rituximab-arrx | Injection, Solution | Intravenous | Human Prescription Drug | ACTIVE |
55513-369 | Otezla | Apremilast | Kit | Human Prescription Drug | ACTIVE | |
55513-399 | Amjevita | Adalimumab-atto | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-400 | Amjevita | Adalimumab-atto | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-410 | Amjevita | Adalimumab-atto | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-411 | Amjevita | Adalimumab-atto | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-413 | Amjevita | Adalimumab-atto | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-478 | Epogen | Epoetin Alfa | Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-479 | Amjevita | Adalimumab-atto | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-480 | Amjevita | Adalimumab-atto | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-481 | Amjevita | Adalimumab-atto | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-482 | Amjevita | Adalimumab-atto | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-485 | Otezla | Apremilast | Kit | Human Prescription Drug | ACTIVE | |
55513-488 | Lumakras | Sotorasib | Tablet, Coated | Oral | Human Prescription Drug | ACTIVE |
55513-504 | Lumakras | Sotorasib | Tablet, Coated | Oral | Human Prescription Drug | ACTIVE |
55513-530 | Neupogen | Filgrastim | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-546 | Neupogen | Filgrastim | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-670 | Avsola | Infliximab-axxq | Injection, Powder, Lyophilized, For Solution | Intravenous | Human Prescription Drug | ACTIVE |
55513-710 | Prolia | Denosumab | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-730 | Xgeva | Denosumab | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-740 | Parsabiv | Etelcalcetide | Injection, Solution | Intravenous | Human Prescription Drug | ACTIVE |
55513-741 | Parsabiv | Etelcalcetide | Injection, Solution | Intravenous | Human Prescription Drug | ACTIVE |
55513-742 | Parsabiv | Etelcalcetide | Injection, Solution | Intravenous | Human Prescription Drug | ACTIVE |
55513-750 | Repatha | Evolocumab | Injection, Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-760 | Repatha | Evolocumab | Injection, Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-770 | Repatha | Evolocumab | Kit | Human Prescription Drug | ACTIVE | |
55513-800 | Corlanor | Ivabradine | Tablet, Film Coated | Oral | Human Prescription Drug | ACTIVE |
55513-810 | Corlanor | Ivabradine | Tablet, Film Coated | Oral | Human Prescription Drug | ACTIVE |
55513-813 | Corlanor | Ivabradine | Solution | Oral | Human Prescription Drug | ACTIVE |
55513-840 | Aimovig | Erenumab-aooe | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-841 | Aimovig | Erenumab-aooe | Injection | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-842 | Aimovig | Erenumab-aooe | Injection, Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-843 | Aimovig | Erenumab-aooe | Injection, Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-880 | Evenity | Romosozumab-aqqg | Injection, Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
55513-924 | Neupogen | Filgrastim | Injection, Solution | Intravenous; Subcutaneous | Human Prescription Drug | ACTIVE |
55513-954 | Vectibix | Panitumumab | Solution | Intravenous | Human Prescription Drug | ACTIVE |
55513-956 | Vectibix | Panitumumab | Solution | Intravenous | Human Prescription Drug | ACTIVE |
55513-101 | Epoetin Alfa | Solution | Drug For Further Processing | UNFINISHED | ||
55513-113 | Epoetin Alfa | Solution | Drug For Further Processing | UNFINISHED | ||
55513-120 | Epoetin Alfa | Solution | Drug For Further Processing | UNFINISHED | ||
55513-136 | Epoetin Alfa | Solution | Drug For Further Processing | UNFINISHED | ||
55513-142 | Epoetin Alfa | Solution | Drug For Further Processing | UNFINISHED | ||
55513-154 | Epoetin Alfa | Solution | Drug For Further Processing | UNFINISHED | ||
55513-168 | Epoetin Alfa | Solution | Drug For Further Processing | UNFINISHED | ||
55513-178 | Etesevimab | Solution | Drug For Further Processing | UNFINISHED | ||
55513-189 | Bebtelovimab | Solution | Drug For Further Processing | UNFINISHED |